Aaron Pruett has the role of Scientist II in Drug Product Process Development at MedImmume, a member of the AstraZeneca group. He is responsible for fill-finish process development and related technical transfer activities. His areas of expertise include protein pharmaceutical process development (such as scaling and process characterization of freeze-thaw and lyophilization unit operations), biophysical and biochemical characterization of pharmaceutical proteins, and characterization of visible and subvisible particles in protein solutions. His previous experience includes working as an engineer in pharmaceutical process development at Human Genome Sciences and Genentech. He received a BS in Chemical Engineering from Virginia Commonwealth University and is currently completing an MS in Biotechnology from Johns Hopkins University.